Evoke Pharma Inc
EVOK
Delayed Nasdaq - 12/13 09:06:47 pm
2.45USD
-8.58%
Upcoming events
03/08/18
FY 2017 Earnings Release (Projected)
05/16/18
Q1 2018 Earnings Release (Projected)
08/13/18
Interim 2018 Earnings Release (Projected)
Past Events
11/14/17 | 10:30pmQ3 2017 Earnings Call
11/14/17Q3 2017 Earnings Release
10/31/17 | 02:00pmGimoti™ Pharmacokinetic Study Results Call
10/11/17Oppenheimer & Co. Specialty Pharmaceuticals Conference - One-on-One Meetings
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-10,5
-9,20
-15%

-12,7
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-10,5
-10,2
-3,5%

-12,3
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-10,7
-11,6
7,0%

-15,0
Net income
Million $
Released
Forecast
Spread
-10,7
-11,3
5,0%

-15,0
EPS
 $
Released
Forecast
Spread
-1,15
-1,28
9,9%

-0,98
Announcement Date03/15/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-3,70
-2,70
-37%

-3,60
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-3,70
-3,12
-19%

-3,27
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-5,24
-3,14
-67%

-3,36
Net income
Million $
Released
Forecast
Spread
-5,24
-3,14
-67%

-3,36
EPS
 $
Released
Forecast
Spread
-0,34
-0,20
-68%

-0,24
Announcement Date11/14/2017
Operating profit - Rate of surprise
EPS - Rate of surprise